FDA and NIH Establish Fast-Track Pathway for Personalized Gene Therapies
The Food and Drug Administration and National Institutes of Health created a coordinated clinical review pathway intended to accelerate safety testing and approval of personalized gene therapies and targeted cancer immunotherapies produced in US laboratories.